

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of integrated proviral latency (GO:0075713) | 5.47855527 |
| 2 | double-strand break repair via nonhomologous end joining (GO:0006303) | 4.43530594 |
| 3 | non-recombinational repair (GO:0000726) | 4.43530594 |
| 4 | DNA ligation (GO:0006266) | 4.34730026 |
| 5 | establishment of viral latency (GO:0019043) | 4.22973787 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.02247421 |
| 7 | formation of translation preinitiation complex (GO:0001731) | 3.97762227 |
| 8 | DNA unwinding involved in DNA replication (GO:0006268) | 3.87135499 |
| 9 | DNA double-strand break processing (GO:0000729) | 3.75212104 |
| 10 | regulation of centriole replication (GO:0046599) | 3.72461447 |
| 11 | protein localization to kinetochore (GO:0034501) | 3.71861675 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.69704291 |
| 13 | mitotic spindle checkpoint (GO:0071174) | 3.63223654 |
| 14 | regulation of helicase activity (GO:0051095) | 3.60852474 |
| 15 | DNA topological change (GO:0006265) | 3.52850130 |
| 16 | histone exchange (GO:0043486) | 3.52232108 |
| 17 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.51468603 |
| 18 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.48975351 |
| 19 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.48975351 |
| 20 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.48975351 |
| 21 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.48975351 |
| 22 | negative regulation of sister chromatid segregation (GO:0033046) | 3.48975351 |
| 23 | COPI coating of Golgi vesicle (GO:0048205) | 3.48921598 |
| 24 | Golgi transport vesicle coating (GO:0048200) | 3.48921598 |
| 25 | negative regulation of chromosome segregation (GO:0051985) | 3.47959282 |
| 26 | mitotic nuclear envelope disassembly (GO:0007077) | 3.47883637 |
| 27 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.44199164 |
| 28 | tRNA aminoacylation for protein translation (GO:0006418) | 3.41225752 |
| 29 | nuclear pore organization (GO:0006999) | 3.40854618 |
| 30 | IMP biosynthetic process (GO:0006188) | 3.38108455 |
| 31 | regulation of sister chromatid segregation (GO:0033045) | 3.36963500 |
| 32 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.36963500 |
| 33 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.36963500 |
| 34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.36395567 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35973039 |
| 36 | mitotic spindle assembly checkpoint (GO:0007094) | 3.34978893 |
| 37 | amino acid activation (GO:0043038) | 3.33041394 |
| 38 | tRNA aminoacylation (GO:0043039) | 3.33041394 |
| 39 | L-serine metabolic process (GO:0006563) | 3.32930812 |
| 40 | response to X-ray (GO:0010165) | 3.31122183 |
| 41 | DNA strand elongation (GO:0022616) | 3.31022237 |
| 42 | membrane disassembly (GO:0030397) | 3.29472021 |
| 43 | nuclear envelope disassembly (GO:0051081) | 3.29472021 |
| 44 | nucleobase biosynthetic process (GO:0046112) | 3.23662912 |
| 45 | ATP-dependent chromatin remodeling (GO:0043044) | 3.22127717 |
| 46 | regulation of spindle organization (GO:0090224) | 3.20857695 |
| 47 | proteasome assembly (GO:0043248) | 3.19592510 |
| 48 | negative regulation of DNA recombination (GO:0045910) | 3.19188370 |
| 49 | protein localization to chromosome, centromeric region (GO:0071459) | 3.18097214 |
| 50 | purine nucleobase biosynthetic process (GO:0009113) | 3.18087117 |
| 51 | pre-miRNA processing (GO:0031054) | 3.16060231 |
| 52 | mitotic G2/M transition checkpoint (GO:0044818) | 3.15134783 |
| 53 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.14771512 |
| 54 | ribosomal small subunit assembly (GO:0000028) | 3.13109687 |
| 55 | nuclear pore complex assembly (GO:0051292) | 3.13064047 |
| 56 | IMP metabolic process (GO:0046040) | 3.12629362 |
| 57 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.10714348 |
| 58 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.09254376 |
| 59 | negative regulation of ligase activity (GO:0051352) | 3.09254376 |
| 60 | B cell mediated immunity (GO:0019724) | 3.07973790 |
| 61 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.04992309 |
| 62 | DNA strand renaturation (GO:0000733) | 3.04252441 |
| 63 | mitotic metaphase plate congression (GO:0007080) | 3.03530293 |
| 64 | telomere maintenance via recombination (GO:0000722) | 3.00493453 |
| 65 | mitotic recombination (GO:0006312) | 2.99362534 |
| 66 | establishment of chromosome localization (GO:0051303) | 2.97678182 |
| 67 | cullin deneddylation (GO:0010388) | 2.97470431 |
| 68 | mitotic chromosome condensation (GO:0007076) | 2.97201626 |
| 69 | isotype switching (GO:0045190) | 2.95834854 |
| 70 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.95834854 |
| 71 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.95834854 |
| 72 | DNA replication initiation (GO:0006270) | 2.95512472 |
| 73 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.94548224 |
| 74 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.94548224 |
| 75 | DNA damage response, detection of DNA damage (GO:0042769) | 2.93954625 |
| 76 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.93693145 |
| 77 | pinocytosis (GO:0006907) | 2.92319818 |
| 78 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91016952 |
| 79 | histone-serine phosphorylation (GO:0035404) | 2.89640487 |
| 80 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.88942650 |
| 81 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.88732929 |
| 82 | regulation of translational termination (GO:0006449) | 2.85727259 |
| 83 | DNA replication checkpoint (GO:0000076) | 2.84244013 |
| 84 | regulation of protein heterodimerization activity (GO:0043497) | 2.81078957 |
| 85 | pore complex assembly (GO:0046931) | 2.79361605 |
| 86 | positive regulation of interferon-alpha production (GO:0032727) | 2.76750415 |
| 87 | immunoglobulin mediated immune response (GO:0016064) | 2.75988919 |
| 88 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.75223909 |
| 89 | actin nucleation (GO:0045010) | 2.73470274 |
| 90 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.71569127 |
| 91 | regulation of mitotic spindle organization (GO:0060236) | 2.69704873 |
| 92 | metaphase plate congression (GO:0051310) | 2.64211005 |
| 93 | negative regulation of phagocytosis (GO:0050765) | 2.63562249 |
| 94 | sister chromatid segregation (GO:0000819) | 2.62701737 |
| 95 | regulation of interferon-alpha production (GO:0032647) | 2.58138210 |
| 96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58124107 |
| 97 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.57570251 |
| 98 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.57570251 |
| 99 | postreplication repair (GO:0006301) | 2.56748337 |
| 100 | nuclear envelope organization (GO:0006998) | 2.54334460 |
| 101 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.52962908 |
| 102 | mitotic sister chromatid segregation (GO:0000070) | 2.52126501 |
| 103 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.52083805 |
| 104 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.52083805 |
| 105 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.52083805 |
| 106 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.51700398 |
| 107 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.51700398 |
| 108 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.50827926 |
| 109 | CENP-A containing nucleosome assembly (GO:0034080) | 2.50376859 |
| 110 | telomere maintenance via telomere lengthening (GO:0010833) | 2.49872207 |
| 111 | ribosome assembly (GO:0042255) | 2.47330803 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.45763638 |
| 113 | mitotic sister chromatid cohesion (GO:0007064) | 2.45727052 |
| 114 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.44976498 |
| 115 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.44976498 |
| 116 | DNA duplex unwinding (GO:0032508) | 2.43107778 |
| 117 | chromatin remodeling at centromere (GO:0031055) | 2.43055112 |
| 118 | DNA geometric change (GO:0032392) | 2.42452768 |
| 119 | dosage compensation (GO:0007549) | 2.41215130 |
| 120 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.39586639 |
| 121 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.39047172 |
| 122 | neutrophil activation involved in immune response (GO:0002283) | 2.37950030 |
| 123 | DNA replication-independent nucleosome organization (GO:0034724) | 2.37499233 |
| 124 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.37499233 |
| 125 | regulation of chromosome segregation (GO:0051983) | 2.37205006 |
| 126 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.36926492 |
| 127 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.36926492 |
| 128 | modulation by symbiont of host immune response (GO:0052553) | 2.36926492 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.36926492 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.36926492 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.36926492 |
| 132 | positive regulation of chromosome segregation (GO:0051984) | 2.36546194 |
| 133 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.36197538 |
| 134 | regulation of sister chromatid cohesion (GO:0007063) | 2.35834058 |
| 135 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.33539593 |
| 136 | protein localization to chromosome (GO:0034502) | 2.33229545 |
| 137 | kinetochore organization (GO:0051383) | 2.31905154 |
| 138 | translesion synthesis (GO:0019985) | 2.30891303 |
| 139 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.30448663 |
| 140 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.30285924 |
| 141 | spindle assembly checkpoint (GO:0071173) | 2.30122411 |
| 142 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.28522781 |
| 143 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.27817356 |
| 144 | positive regulation of lamellipodium assembly (GO:0010592) | 2.27719673 |
| 145 | spindle checkpoint (GO:0031577) | 2.27291222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.81656177 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.91393758 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54228602 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.27041416 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.08108038 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.00449882 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.66739922 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.55572875 |
| 9 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.55386485 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.32233878 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20100890 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18868109 |
| 13 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.12392180 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.07095560 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01601445 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.99575413 |
| 17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.98330181 |
| 18 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.97308148 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95855982 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.95479894 |
| 21 | * MYC_22102868_ChIP-Seq_BL_Human | 1.94397021 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.93399767 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.90524227 |
| 24 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89489173 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88781304 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87767988 |
| 27 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.83551723 |
| 28 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.77745893 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75741339 |
| 30 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.74790564 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67451663 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67243722 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65938142 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.65231260 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63587206 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62826548 |
| 37 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62298492 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61403343 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61196608 |
| 40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59785154 |
| 41 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.59372303 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.58816583 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.58525995 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55958278 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.52491429 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50635771 |
| 47 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49874775 |
| 48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.48683459 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47821271 |
| 50 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46811748 |
| 51 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.46504047 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45948272 |
| 53 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.45513876 |
| 54 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45101018 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42207587 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40891346 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40739715 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40203120 |
| 59 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39637752 |
| 60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.37994427 |
| 61 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.37097166 |
| 62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.36334442 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35584059 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35552193 |
| 65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33619805 |
| 66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33452769 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32005800 |
| 68 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.31299318 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30040063 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29070520 |
| 71 | MYB_26560356_Chip-Seq_TH2_Human | 1.27111980 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.26162760 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25905031 |
| 74 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22905050 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20753428 |
| 76 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20193944 |
| 77 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.19822312 |
| 78 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.19690792 |
| 79 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.19017673 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18886552 |
| 81 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.17905714 |
| 82 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16346650 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.15965468 |
| 84 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15449866 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14424841 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14280346 |
| 87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13499593 |
| 88 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13041475 |
| 89 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.12047489 |
| 90 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.11854635 |
| 91 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11557214 |
| 92 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10067960 |
| 93 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.09805713 |
| 94 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06315558 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05773181 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04788960 |
| 97 | * MYB_26560356_Chip-Seq_TH1_Human | 1.04190162 |
| 98 | * MAF_26560356_Chip-Seq_TH1_Human | 1.02410447 |
| 99 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02186976 |
| 100 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01266059 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01001807 |
| 102 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00396610 |
| 103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99772546 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99052202 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.97673260 |
| 106 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97208455 |
| 107 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95639353 |
| 108 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95514581 |
| 109 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94815755 |
| 110 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94802683 |
| 111 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94224675 |
| 112 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.93527098 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92798335 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92739280 |
| 115 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91952949 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90559881 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90385337 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90275196 |
| 119 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88154508 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87000588 |
| 121 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85993530 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84809905 |
| 123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84363197 |
| 124 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84303508 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84279100 |
| 126 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.82726121 |
| 127 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.82515194 |
| 128 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.82390402 |
| 129 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82367667 |
| 130 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82325978 |
| 131 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.81832816 |
| 132 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.81432384 |
| 133 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80178088 |
| 134 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.76883923 |
| 135 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76332848 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76218813 |
| 137 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.75464956 |
| 138 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.74568774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.13462024 |
| 2 | MP0003941_abnormal_skin_development | 3.09934165 |
| 3 | MP0003693_abnormal_embryo_hatching | 2.84782525 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 2.81677742 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 2.62807732 |
| 6 | MP0006054_spinal_hemorrhage | 2.42423700 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.40086799 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.38799021 |
| 9 | MP0003077_abnormal_cell_cycle | 2.36559444 |
| 10 | MP0003718_maternal_effect | 2.25963015 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 2.24733993 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.07802199 |
| 13 | MP0003436_decreased_susceptibility_to | 2.07042820 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.06417871 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.02492286 |
| 16 | MP0010307_abnormal_tumor_latency | 1.95189220 |
| 17 | MP0001293_anophthalmia | 1.92040978 |
| 18 | MP0002396_abnormal_hematopoietic_system | 1.85852918 |
| 19 | MP0008057_abnormal_DNA_replication | 1.80542463 |
| 20 | MP0003566_abnormal_cell_adhesion | 1.79840633 |
| 21 | MP0003303_peritoneal_inflammation | 1.77277609 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.76991665 |
| 23 | MP0009672_abnormal_birth_weight | 1.71147879 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.68929730 |
| 25 | MP0002254_reproductive_system_inflammat | 1.67016478 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.59182268 |
| 27 | MP0001800_abnormal_humoral_immune | 1.58447787 |
| 28 | MP0001730_embryonic_growth_arrest | 1.57872241 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.57164340 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.53572802 |
| 31 | MP0000490_abnormal_crypts_of | 1.51297491 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.51088250 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.50926220 |
| 34 | MP0002419_abnormal_innate_immunity | 1.48930578 |
| 35 | MP0000685_abnormal_immune_system | 1.48733575 |
| 36 | MP0003123_paternal_imprinting | 1.48469695 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.48448222 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.47810137 |
| 39 | MP0002085_abnormal_embryonic_tissue | 1.47046449 |
| 40 | MP0000350_abnormal_cell_proliferation | 1.44525574 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.44063531 |
| 42 | MP0009785_altered_susceptibility_to | 1.42266841 |
| 43 | MP0003786_premature_aging | 1.41343423 |
| 44 | MP0001819_abnormal_immune_cell | 1.40842148 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.39679162 |
| 46 | MP0000858_altered_metastatic_potential | 1.39553274 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.36610185 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.35817399 |
| 49 | MP0002398_abnormal_bone_marrow | 1.34463921 |
| 50 | MP0008932_abnormal_embryonic_tissue | 1.33874378 |
| 51 | MP0005671_abnormal_response_to | 1.33809245 |
| 52 | MP0005023_abnormal_wound_healing | 1.32226816 |
| 53 | MP0002009_preneoplasia | 1.31999903 |
| 54 | MP0002796_impaired_skin_barrier | 1.30946520 |
| 55 | MP0005025_abnormal_response_to | 1.30810702 |
| 56 | MP0003937_abnormal_limbs/digits/tail_de | 1.28052746 |
| 57 | MP0002723_abnormal_immune_serum | 1.27696746 |
| 58 | MP0003121_genomic_imprinting | 1.24272368 |
| 59 | MP0001286_abnormal_eye_development | 1.24270885 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.23332515 |
| 61 | MP0003448_altered_tumor_morphology | 1.23230468 |
| 62 | MP0000647_abnormal_sebaceous_gland | 1.22138667 |
| 63 | MP0006292_abnormal_olfactory_placode | 1.19243424 |
| 64 | MP0006082_CNS_inflammation | 1.19214418 |
| 65 | MP0002722_abnormal_immune_system | 1.18398641 |
| 66 | MP0002697_abnormal_eye_size | 1.17906853 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.17577677 |
| 68 | MP0000716_abnormal_immune_system | 1.16916389 |
| 69 | MP0002405_respiratory_system_inflammati | 1.16810150 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.16794032 |
| 71 | MP0002006_tumorigenesis | 1.16626440 |
| 72 | MP0005275_abnormal_skin_tensile | 1.15611026 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.15455621 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 1.15150466 |
| 75 | MP0001853_heart_inflammation | 1.15063123 |
| 76 | MP0001697_abnormal_embryo_size | 1.14824154 |
| 77 | MP0001915_intracranial_hemorrhage | 1.13741586 |
| 78 | MP0010678_abnormal_skin_adnexa | 1.13672608 |
| 79 | MP0002429_abnormal_blood_cell | 1.13519681 |
| 80 | MP0005387_immune_system_phenotype | 1.13238245 |
| 81 | MP0001790_abnormal_immune_system | 1.13238245 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.12984523 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 1.10976090 |
| 84 | MP0001545_abnormal_hematopoietic_system | 1.10976090 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.10560047 |
| 86 | MP0005501_abnormal_skin_physiology | 1.10063833 |
| 87 | MP0001666_abnormal_nutrient_absorption | 1.08789151 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 1.08661173 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.08558184 |
| 90 | MP0009053_abnormal_anal_canal | 1.08068776 |
| 91 | MP0003984_embryonic_growth_retardation | 1.07808675 |
| 92 | MP0002086_abnormal_extraembryonic_tissu | 1.07520896 |
| 93 | MP0002088_abnormal_embryonic_growth/wei | 1.07069577 |
| 94 | MP0005380_embryogenesis_phenotype | 1.04797269 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 1.04797269 |
| 96 | MP0009703_decreased_birth_body | 1.04576992 |
| 97 | MP0006072_abnormal_retinal_apoptosis | 1.03196400 |
| 98 | MP0005499_abnormal_olfactory_system | 1.03059201 |
| 99 | MP0005394_taste/olfaction_phenotype | 1.03059201 |
| 100 | MP0003315_abnormal_perineum_morphology | 1.01466233 |
| 101 | MP0002080_prenatal_lethality | 1.00894506 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 1.00827954 |
| 103 | MP0000343_altered_response_to | 1.00396459 |
| 104 | MP0008058_abnormal_DNA_repair | 1.00123194 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.99377003 |
| 106 | MP0002233_abnormal_nose_morphology | 0.98509994 |
| 107 | MP0005408_hypopigmentation | 0.95877339 |
| 108 | MP0003186_abnormal_redox_activity | 0.95238034 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.94547257 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.93610348 |
| 111 | MP0002111_abnormal_tail_morphology | 0.93051951 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.91259250 |
| 113 | MP0001881_abnormal_mammary_gland | 0.91100336 |
| 114 | MP0004947_skin_inflammation | 0.90703654 |
| 115 | MP0005248_abnormal_Harderian_gland | 0.90694725 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.90508067 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.90453171 |
| 118 | MP0001958_emphysema | 0.89850382 |
| 119 | MP0000313_abnormal_cell_death | 0.89474210 |
| 120 | MP0002092_abnormal_eye_morphology | 0.88327903 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87595703 |
| 122 | MP0001849_ear_inflammation | 0.86787070 |
| 123 | MP0000598_abnormal_liver_morphology | 0.85906652 |
| 124 | MP0004197_abnormal_fetal_growth/weight/ | 0.84838213 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.84630498 |
| 126 | MP0004272_abnormal_basement_membrane | 0.84041781 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.83813245 |
| 128 | MP0005384_cellular_phenotype | 0.83377623 |
| 129 | MP0000428_abnormal_craniofacial_morphol | 0.83178767 |
| 130 | MP0003119_abnormal_digestive_system | 0.81605728 |
| 131 | MP0002751_abnormal_autonomic_nervous | 0.81505337 |
| 132 | MP0008469_abnormal_protein_level | 0.79692258 |
| 133 | MP0003279_aneurysm | 0.78568346 |
| 134 | MP0001727_abnormal_embryo_implantation | 0.77267600 |
| 135 | MP0000377_abnormal_hair_follicle | 0.77150992 |
| 136 | MP0001661_extended_life_span | 0.76362557 |
| 137 | MP0002938_white_spotting | 0.76316568 |
| 138 | MP0010030_abnormal_orbit_morphology | 0.76309687 |
| 139 | MP0003868_abnormal_feces_composition | 0.75930344 |
| 140 | MP0009840_abnormal_foam_cell | 0.75618768 |
| 141 | MP0005395_other_phenotype | 0.74813759 |
| 142 | MP0009697_abnormal_copulation | 0.74123164 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74064220 |
| 144 | MP0002084_abnormal_developmental_patter | 0.73005423 |
| 145 | MP0000358_abnormal_cell_content/ | 0.72714755 |
| 146 | MP0000371_diluted_coat_color | 0.72232578 |
| 147 | MP0000427_abnormal_hair_cycle | 0.71840053 |
| 148 | MP0000477_abnormal_intestine_morphology | 0.69314027 |
| 149 | MP0010368_abnormal_lymphatic_system | 0.68275966 |
| 150 | MP0000627_abnormal_mammary_gland | 0.67764556 |
| 151 | MP0001216_abnormal_epidermal_layer | 0.66686745 |
| 152 | MP0001119_abnormal_female_reproductive | 0.66117091 |
| 153 | MP0005621_abnormal_cell_physiology | 0.64866804 |
| 154 | MP0001243_abnormal_dermal_layer | 0.64007974 |
| 155 | MP0003950_abnormal_plasma_membrane | 0.63695143 |
| 156 | MP0000383_abnormal_hair_follicle | 0.62055299 |
| 157 | MP0001145_abnormal_male_reproductive | 0.60798464 |
| 158 | MP0001929_abnormal_gametogenesis | 0.60611797 |
| 159 | MP0001529_abnormal_vocalization | 0.60505689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.03526705 |
| 2 | Chromsome breakage (HP:0040012) | 3.86857815 |
| 3 | Agnosia (HP:0010524) | 3.59641288 |
| 4 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.56033241 |
| 5 | Abnormality of chromosome stability (HP:0003220) | 3.46136340 |
| 6 | Rhabdomyosarcoma (HP:0002859) | 3.42970183 |
| 7 | Thrombocytosis (HP:0001894) | 3.42590500 |
| 8 | Embryonal renal neoplasm (HP:0011794) | 3.38846506 |
| 9 | Abnormality of the anterior horn cell (HP:0006802) | 3.36931193 |
| 10 | Degeneration of anterior horn cells (HP:0002398) | 3.36931193 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.22822176 |
| 12 | Abnormal lung lobation (HP:0002101) | 3.21862346 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.10088043 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.09797217 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.08264855 |
| 16 | Increased serum pyruvate (HP:0003542) | 3.02465045 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 3.01154318 |
| 18 | Abnormality of the labia minora (HP:0012880) | 2.99854506 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 2.97682233 |
| 20 | Abnormality of glycolysis (HP:0004366) | 2.93343829 |
| 21 | Medulloblastoma (HP:0002885) | 2.92800165 |
| 22 | Meckel diverticulum (HP:0002245) | 2.85312602 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.84081805 |
| 24 | Hematochezia (HP:0002573) | 2.76277779 |
| 25 | Ependymoma (HP:0002888) | 2.72205962 |
| 26 | Abnormality of the ileum (HP:0001549) | 2.69467332 |
| 27 | IgM deficiency (HP:0002850) | 2.69104373 |
| 28 | Abnormality of the preputium (HP:0100587) | 2.64190777 |
| 29 | Disinhibition (HP:0000734) | 2.61360810 |
| 30 | Cervical subluxation (HP:0003308) | 2.60735530 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.58016260 |
| 32 | Papillary thyroid carcinoma (HP:0002895) | 2.55833197 |
| 33 | Volvulus (HP:0002580) | 2.53922155 |
| 34 | Poor head control (HP:0002421) | 2.52464540 |
| 35 | Gonadotropin excess (HP:0000837) | 2.51368926 |
| 36 | Increased nuchal translucency (HP:0010880) | 2.50168948 |
| 37 | Colon cancer (HP:0003003) | 2.46569872 |
| 38 | Small intestinal stenosis (HP:0012848) | 2.45495509 |
| 39 | Duodenal stenosis (HP:0100867) | 2.45495509 |
| 40 | Abnormality of complement system (HP:0005339) | 2.40018462 |
| 41 | Breast carcinoma (HP:0003002) | 2.39060364 |
| 42 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.38903469 |
| 43 | Myositis (HP:0100614) | 2.38485259 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35576510 |
| 45 | Microvesicular hepatic steatosis (HP:0001414) | 2.33231658 |
| 46 | Myelodysplasia (HP:0002863) | 2.30119555 |
| 47 | Protrusio acetabuli (HP:0003179) | 2.29411825 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.28719151 |
| 49 | Osteolytic defects of the hand bones (HP:0009699) | 2.28537675 |
| 50 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28537675 |
| 51 | Cortical dysplasia (HP:0002539) | 2.27773128 |
| 52 | Cellulitis (HP:0100658) | 2.27325202 |
| 53 | Mucosal telangiectasiae (HP:0100579) | 2.26621297 |
| 54 | Thyroid carcinoma (HP:0002890) | 2.26391464 |
| 55 | Stenosis of the external auditory canal (HP:0000402) | 2.26124878 |
| 56 | Deep philtrum (HP:0002002) | 2.25882838 |
| 57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.25817216 |
| 58 | Abnormality of the duodenum (HP:0002246) | 2.22629940 |
| 59 | Birth length less than 3rd percentile (HP:0003561) | 2.20124893 |
| 60 | Oral leukoplakia (HP:0002745) | 2.19613897 |
| 61 | Gastrointestinal carcinoma (HP:0002672) | 2.18545485 |
| 62 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.18545485 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.17772527 |
| 64 | Aortic aneurysm (HP:0004942) | 2.14940946 |
| 65 | Biliary tract neoplasm (HP:0100574) | 2.14325886 |
| 66 | Ovarian neoplasm (HP:0100615) | 2.11045835 |
| 67 | Supernumerary spleens (HP:0009799) | 2.09527245 |
| 68 | Cutaneous melanoma (HP:0012056) | 2.09258163 |
| 69 | Abnormality of serum amino acid levels (HP:0003112) | 2.08242733 |
| 70 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.05430924 |
| 71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.04094353 |
| 72 | Horseshoe kidney (HP:0000085) | 2.02775471 |
| 73 | Syringomyelia (HP:0003396) | 2.02568865 |
| 74 | Spinal cord lesions (HP:0100561) | 2.02568865 |
| 75 | Osteomyelitis (HP:0002754) | 2.02429679 |
| 76 | Recurrent viral infections (HP:0004429) | 2.02091622 |
| 77 | Spinal muscular atrophy (HP:0007269) | 2.01965475 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.00447310 |
| 79 | Neoplasm of the colon (HP:0100273) | 2.00412671 |
| 80 | Intrahepatic cholestasis (HP:0001406) | 2.00210259 |
| 81 | Hypobetalipoproteinemia (HP:0003563) | 2.00181911 |
| 82 | Termporal pattern (HP:0011008) | 1.99752790 |
| 83 | Insidious onset (HP:0003587) | 1.99752790 |
| 84 | Spontaneous hematomas (HP:0007420) | 1.95905303 |
| 85 | Glioma (HP:0009733) | 1.95646533 |
| 86 | Neoplasm of the adrenal gland (HP:0100631) | 1.93927433 |
| 87 | Neoplasm of the rectum (HP:0100743) | 1.93619366 |
| 88 | Hypoplastic pelvis (HP:0008839) | 1.92717052 |
| 89 | Multiple enchondromatosis (HP:0005701) | 1.92544990 |
| 90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91390288 |
| 91 | Embryonal neoplasm (HP:0002898) | 1.89620303 |
| 92 | Sloping forehead (HP:0000340) | 1.89347889 |
| 93 | Increased hepatocellular lipid droplets (HP:0006565) | 1.88622485 |
| 94 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88617796 |
| 95 | Cerebral aneurysm (HP:0004944) | 1.88568703 |
| 96 | Curly hair (HP:0002212) | 1.88392105 |
| 97 | Posterior subcapsular cataract (HP:0007787) | 1.87873075 |
| 98 | Neoplasm of striated muscle (HP:0009728) | 1.86909910 |
| 99 | Spastic diplegia (HP:0001264) | 1.86508675 |
| 100 | Glomerulonephritis (HP:0000099) | 1.86110656 |
| 101 | Abnormality of macrophages (HP:0004311) | 1.85701157 |
| 102 | Vertebral compression fractures (HP:0002953) | 1.85508752 |
| 103 | Short humerus (HP:0005792) | 1.85055942 |
| 104 | Ascites (HP:0001541) | 1.84892293 |
| 105 | Pustule (HP:0200039) | 1.83191532 |
| 106 | Bifid tongue (HP:0010297) | 1.82213531 |
| 107 | Lymphoma (HP:0002665) | 1.81878032 |
| 108 | Uterine leiomyosarcoma (HP:0002891) | 1.81876736 |
| 109 | Leiomyosarcoma (HP:0100243) | 1.81876736 |
| 110 | Metaphyseal cupping (HP:0003021) | 1.81231778 |
| 111 | Aplastic anemia (HP:0001915) | 1.81037728 |
| 112 | Abnormal biliary tract physiology (HP:0012439) | 1.80665287 |
| 113 | Bile duct proliferation (HP:0001408) | 1.80665287 |
| 114 | Abnormal foot bone ossification (HP:0010675) | 1.80452882 |
| 115 | Postnatal microcephaly (HP:0005484) | 1.79137055 |
| 116 | Progressive external ophthalmoplegia (HP:0000590) | 1.78790906 |
| 117 | Microglossia (HP:0000171) | 1.78708929 |
| 118 | Reticulocytopenia (HP:0001896) | 1.78626562 |
| 119 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78583487 |
| 120 | Obstructive lung disease (HP:0006536) | 1.78583487 |
| 121 | Intestinal atresia (HP:0011100) | 1.78288978 |
| 122 | Hepatoblastoma (HP:0002884) | 1.77435263 |
| 123 | Adrenal hypoplasia (HP:0000835) | 1.77074596 |
| 124 | Periodontitis (HP:0000704) | 1.76943195 |
| 125 | Choanal atresia (HP:0000453) | 1.76892677 |
| 126 | Hyperglycinemia (HP:0002154) | 1.76796060 |
| 127 | Recurrent bronchitis (HP:0002837) | 1.75690801 |
| 128 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75482974 |
| 129 | Abnormality of glycine metabolism (HP:0010895) | 1.75482974 |
| 130 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74639382 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.74407152 |
| 132 | Cholecystitis (HP:0001082) | 1.74407152 |
| 133 | Secondary amenorrhea (HP:0000869) | 1.74066061 |
| 134 | Subacute progressive viral hepatitis (HP:0006572) | 1.74052025 |
| 135 | Hypoglycemic seizures (HP:0002173) | 1.73952912 |
| 136 | Ankle contracture (HP:0006466) | 1.73839222 |
| 137 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.73654522 |
| 138 | High pitched voice (HP:0001620) | 1.73652926 |
| 139 | Symptomatic seizures (HP:0011145) | 1.73401714 |
| 140 | Increased mean platelet volume (HP:0011877) | 1.73141273 |
| 141 | Skull defect (HP:0001362) | 1.73091058 |
| 142 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.72870713 |
| 143 | Diminished motivation (HP:0000745) | 1.72508258 |
| 144 | Amaurosis fugax (HP:0100576) | 1.72501228 |
| 145 | Orchitis (HP:0100796) | 1.72201385 |
| 146 | Arterial thrombosis (HP:0004420) | 1.72117371 |
| 147 | Deviation of the thumb (HP:0009603) | 1.71802230 |
| 148 | Absent radius (HP:0003974) | 1.71695596 |
| 149 | Abnormality of the calcaneus (HP:0008364) | 1.71459285 |
| 150 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.71341744 |
| 151 | Abnormal platelet volume (HP:0011876) | 1.71274676 |
| 152 | Neoplasm of the small intestine (HP:0100833) | 1.70884863 |
| 153 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.70807970 |
| 154 | Prominent metopic ridge (HP:0005487) | 1.70691921 |
| 155 | Dysostosis multiplex (HP:0000943) | 1.70347515 |
| 156 | Overlapping toe (HP:0001845) | 1.70195497 |
| 157 | Increased density of long bones (HP:0006392) | 1.69841608 |
| 158 | Carpal bone hypoplasia (HP:0001498) | 1.68903754 |
| 159 | IgA deficiency (HP:0002720) | 1.68864019 |
| 160 | Upper motor neuron abnormality (HP:0002127) | 1.68365940 |
| 161 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.68235650 |
| 162 | Astrocytoma (HP:0009592) | 1.67985292 |
| 163 | Abnormality of the astrocytes (HP:0100707) | 1.67985292 |
| 164 | Recurrent pneumonia (HP:0006532) | 1.67718736 |
| 165 | Abnormality of T cell physiology (HP:0011840) | 1.67465959 |
| 166 | Personality changes (HP:0000751) | 1.66974607 |
| 167 | Striae distensae (HP:0001065) | 1.66864549 |
| 168 | Recurrent fungal infections (HP:0002841) | 1.66352967 |
| 169 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65644747 |
| 170 | Mucopolysacchariduria (HP:0008155) | 1.65644747 |
| 171 | Uterine neoplasm (HP:0010784) | 1.64863366 |
| 172 | Lymphopenia (HP:0001888) | 1.63292145 |
| 173 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.62894667 |
| 174 | Short 4th metacarpal (HP:0010044) | 1.62894667 |
| 175 | Selective tooth agenesis (HP:0001592) | 1.61582896 |
| 176 | Bicuspid aortic valve (HP:0001647) | 1.61067741 |
| 177 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.60593856 |
| 178 | Conjunctival telangiectasia (HP:0000524) | 1.60451311 |
| 179 | Aortic dissection (HP:0002647) | 1.59849994 |
| 180 | Abnormality of the lumbar spine (HP:0100712) | 1.59361931 |
| 181 | Mediastinal lymphadenopathy (HP:0100721) | 1.58788245 |
| 182 | Beaking of vertebral bodies (HP:0004568) | 1.58269635 |
| 183 | Abnormality of the motor neurons (HP:0002450) | 1.58123925 |
| 184 | Abnormal neuron morphology (HP:0012757) | 1.58123925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 3.35242607 |
| 2 | EIF2AK1 | 2.85452088 |
| 3 | CDC7 | 2.57483210 |
| 4 | BUB1 | 2.52807320 |
| 5 | SCYL2 | 2.50612047 |
| 6 | WEE1 | 2.46652826 |
| 7 | NEK1 | 2.44899660 |
| 8 | MKNK2 | 2.26845392 |
| 9 | NEK9 | 2.18216439 |
| 10 | STK10 | 2.15016740 |
| 11 | MAP4K1 | 2.07174354 |
| 12 | PKN2 | 2.06939102 |
| 13 | BRSK2 | 2.06903876 |
| 14 | TSSK6 | 2.06230803 |
| 15 | BCR | 2.04147872 |
| 16 | TGFBR1 | 2.01787083 |
| 17 | FLT3 | 2.00166515 |
| 18 | ACVR1B | 1.99158656 |
| 19 | RPS6KA4 | 1.97581235 |
| 20 | TAF1 | 1.88454581 |
| 21 | PLK4 | 1.87675038 |
| 22 | NEK2 | 1.86625979 |
| 23 | BLK | 1.82659730 |
| 24 | TGFBR2 | 1.76890840 |
| 25 | PASK | 1.72274774 |
| 26 | ZAK | 1.70174122 |
| 27 | EEF2K | 1.68787973 |
| 28 | LRRK2 | 1.66611927 |
| 29 | NUAK1 | 1.58521908 |
| 30 | PAK4 | 1.50580789 |
| 31 | CSF1R | 1.50140681 |
| 32 | ZAP70 | 1.40371193 |
| 33 | TYK2 | 1.40220148 |
| 34 | MAP3K12 | 1.38871299 |
| 35 | VRK2 | 1.38238907 |
| 36 | TESK1 | 1.37354051 |
| 37 | TESK2 | 1.37132325 |
| 38 | PLK3 | 1.36643128 |
| 39 | TRIB3 | 1.33278281 |
| 40 | ERN1 | 1.28971471 |
| 41 | PIM2 | 1.28199728 |
| 42 | MAP3K8 | 1.26323944 |
| 43 | CDK6 | 1.25216785 |
| 44 | EIF2AK3 | 1.23410814 |
| 45 | MAP2K3 | 1.22513749 |
| 46 | JAK3 | 1.20062516 |
| 47 | FRK | 1.17608127 |
| 48 | TBK1 | 1.17471393 |
| 49 | NME2 | 1.14243601 |
| 50 | SIK3 | 1.12472993 |
| 51 | TIE1 | 1.12059312 |
| 52 | RPS6KB2 | 1.09325782 |
| 53 | WNK3 | 1.08064109 |
| 54 | TTK | 1.07964986 |
| 55 | STK38L | 1.07626399 |
| 56 | STK16 | 1.07043017 |
| 57 | KIT | 1.06732217 |
| 58 | MST4 | 1.05788814 |
| 59 | PLK1 | 1.05554279 |
| 60 | MAP3K14 | 1.03738990 |
| 61 | AURKB | 1.02994256 |
| 62 | CDK19 | 1.01671622 |
| 63 | EIF2AK2 | 1.00445302 |
| 64 | CLK1 | 0.98701015 |
| 65 | CCNB1 | 0.94497882 |
| 66 | BTK | 0.94336540 |
| 67 | STK3 | 0.93770891 |
| 68 | PIM1 | 0.92972982 |
| 69 | BRD4 | 0.90414475 |
| 70 | PLK2 | 0.90178107 |
| 71 | PDK2 | 0.90150259 |
| 72 | ERBB3 | 0.88086170 |
| 73 | ATM | 0.88061011 |
| 74 | ATR | 0.87357053 |
| 75 | MKNK1 | 0.85460308 |
| 76 | BRSK1 | 0.84759345 |
| 77 | FGFR3 | 0.84536238 |
| 78 | CDK4 | 0.84226523 |
| 79 | PTK6 | 0.83008971 |
| 80 | TEC | 0.82558590 |
| 81 | MAPKAPK3 | 0.81897998 |
| 82 | ERBB4 | 0.79931557 |
| 83 | TNIK | 0.79555674 |
| 84 | KDR | 0.67778103 |
| 85 | MAP3K3 | 0.67476519 |
| 86 | SYK | 0.66408933 |
| 87 | CSNK1G1 | 0.66210181 |
| 88 | MAP3K4 | 0.65765735 |
| 89 | ALK | 0.64385737 |
| 90 | KSR1 | 0.61778289 |
| 91 | MAP3K10 | 0.61121401 |
| 92 | STK4 | 0.60482020 |
| 93 | ITK | 0.60158438 |
| 94 | SMG1 | 0.59175140 |
| 95 | SRPK1 | 0.58728684 |
| 96 | LYN | 0.58233580 |
| 97 | JAK1 | 0.57806202 |
| 98 | CHUK | 0.57430314 |
| 99 | IKBKB | 0.57211882 |
| 100 | MATK | 0.57133631 |
| 101 | MELK | 0.56256256 |
| 102 | BMPR1B | 0.55978295 |
| 103 | CSNK1G3 | 0.54624368 |
| 104 | CSK | 0.54210634 |
| 105 | IRAK4 | 0.54032196 |
| 106 | CDK8 | 0.54011168 |
| 107 | BRAF | 0.53765375 |
| 108 | MAP4K2 | 0.53400596 |
| 109 | YES1 | 0.52967511 |
| 110 | LIMK1 | 0.52755036 |
| 111 | CSNK2A2 | 0.52241061 |
| 112 | RIPK1 | 0.51868273 |
| 113 | PDK4 | 0.51703438 |
| 114 | PDK3 | 0.51703438 |
| 115 | CDK7 | 0.50555022 |
| 116 | DYRK3 | 0.50214972 |
| 117 | CSNK1E | 0.50095047 |
| 118 | PBK | 0.49350226 |
| 119 | STK24 | 0.48957853 |
| 120 | MAP3K5 | 0.48483816 |
| 121 | CDK18 | 0.47703386 |
| 122 | DAPK1 | 0.47572438 |
| 123 | CSNK1G2 | 0.47084925 |
| 124 | FGFR1 | 0.47041172 |
| 125 | CSNK2A1 | 0.46588685 |
| 126 | JAK2 | 0.45170758 |
| 127 | VRK1 | 0.44870020 |
| 128 | TAOK2 | 0.44330413 |
| 129 | CHEK1 | 0.44166693 |
| 130 | CSNK1A1L | 0.44118050 |
| 131 | BMPR2 | 0.43917634 |
| 132 | CDK1 | 0.43362951 |
| 133 | CHEK2 | 0.43324189 |
| 134 | LCK | 0.42796215 |
| 135 | FGFR4 | 0.42743523 |
| 136 | MARK3 | 0.42150345 |
| 137 | CDK2 | 0.41599456 |
| 138 | MAPKAPK2 | 0.41575490 |
| 139 | LATS1 | 0.40814747 |
| 140 | AURKA | 0.40705695 |
| 141 | CDK14 | 0.40067966 |
| 142 | EPHA2 | 0.38069626 |
| 143 | STK39 | 0.37862834 |
| 144 | TLK1 | 0.37497000 |
| 145 | OXSR1 | 0.36866671 |
| 146 | CDK15 | 0.34389557 |
| 147 | FER | 0.31734268 |
| 148 | BCKDK | 0.31708664 |
| 149 | PRKDC | 0.31663343 |
| 150 | CDK11A | 0.31191980 |
| 151 | ILK | 0.31046209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.73249627 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.06722132 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.60977054 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.56681528 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.33649688 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.26702191 |
| 7 | Cell cycle_Homo sapiens_hsa04110 | 2.25586732 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.18260489 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17933762 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13037922 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.03961601 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.02611894 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.00739553 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.95656772 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.92112269 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.83937203 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.72416612 |
| 18 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.71926572 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.56614054 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56086052 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53756668 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47471706 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45833541 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.44236976 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.38395603 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36307121 |
| 27 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.35720490 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34629246 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29584296 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.28695756 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.25114778 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24857480 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.24273065 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23746420 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21806529 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.19133649 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16953757 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14400180 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13385838 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.12393144 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.11221504 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10470061 |
| 43 | RNA polymerase_Homo sapiens_hsa03020 | 1.08985688 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06157557 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.05603962 |
| 46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.03715501 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02765405 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01537718 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00116738 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99349918 |
| 51 | Measles_Homo sapiens_hsa05162 | 0.99098624 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.98196055 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96769527 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95555558 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93998263 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93434491 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.92849826 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.90430591 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.89217038 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89164114 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88351164 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.88087270 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88064791 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87662213 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86293759 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.85596250 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85240964 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85132043 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84495251 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83393175 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83131816 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82962594 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81497287 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81396168 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81227048 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80848661 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.79985327 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.77684034 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76098882 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73772389 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71867912 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.71299270 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70528092 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69627222 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68841483 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68676498 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68622029 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.68314228 |
| 89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67646756 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65874860 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64872867 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63925406 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62568714 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.62214243 |
| 95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.61810601 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61614028 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58692459 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.57843878 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57491591 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56582446 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56382547 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56254485 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55660379 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55486952 |
| 105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54860612 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54846947 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53609499 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.52649423 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51774444 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51717331 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51664238 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51291336 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50089022 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49961689 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49947116 |
| 116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48061220 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47671563 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | 0.46366159 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.46027411 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45941354 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.43416258 |
| 122 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42577474 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41013156 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39822829 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39587067 |
| 126 | Lysine degradation_Homo sapiens_hsa00310 | 0.37351690 |
| 127 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37349484 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35341017 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.31998010 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.31691923 |
| 131 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31576656 |
| 132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31116016 |
| 133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.30262312 |
| 134 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29582380 |
| 135 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28122889 |
| 136 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27933112 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27855282 |
| 138 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20204431 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.19430267 |
| 140 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.15901002 |

